Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 6/20 | 0.68 |
| ▸ | NPC1 | O15118 | 6/20 | 0.68 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.68 |
| ▸ | MEN1 | O00255 | 1/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.56 |
| ▸ | HPGD | P15428 | 1/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.55 |
| ▸ | NAMPT | P43490 | 3/20 | 0.54 |
| ▸ | USP2 | O75604 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7901196 | 0.92 | RAB9A (0.59) | RAB9ANPC1EPHX2KMT2AMEN1 | |
| SCHEMBL23680252 | 0.84 | RAB9A (0.71) | RAB9ANPC1EPHX2KMT2AMEN1 | |
| SCHEMBL5647839 | 0.83 | EPHX2 (0.73) | RAB9ANPC1EPHX2KMT2AMEN1 | |
| SCHEMBL11520494 | 0.83 | RAB9A (0.97) | RAB9ANPC1EPHX2KMT2AMEN1 | |
| SCHEMBL27396494 | 0.81 | KMT2A (0.71) | RAB9ANPC1EPHX2KMT2AMEN1 | |
| SCHEMBL20852858 | 0.81 | RAB9A (0.71) | RAB9ANPC1EPHX2KMT2AMEN1 | |
| SCHEMBL22808948 | 0.81 | RAB9A (0.71) | RAB9ANPC1EPHX2KMT2AMEN1 | |
| SCHEMBL3822162 | 0.81 | EPHX2 (1.00) | RAB9ANPC1EPHX2KMT2ASMN1; SMN2 | |
| SCHEMBL15376425 | 0.81 | EPHX2 (0.70) | RAB9ANPC1EPHX2KMT2AMEN1 | |
| SCHEMBL12931990 | 0.81 | EPHX2 (1.00) | RAB9ANPC1EPHX2KMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230053746-A1 | IL-17 LIGANDS AND USES THEREOF | DICE MOLECULES SV, INC. | 2023-02-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230053746-A1 | IL-17 LIGANDS AND USES THEREOF | IL17A, IL2, IL15 | RAB9A 3112/4885NPC1 3473/4885EPHX2 2174/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.